Rabies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Rabies symptoms include loss of feeling in an area of the body, loss of muscle function, swallowing difficult, excitability, fever, and convulsions.
The Rabies pipeline drugs market research report provides an analysis of the Rabies drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Rabies and features dormant and discontinued projects.
Rabies Pipeline Drugs Market Segmentation by Target
The target of the Rabies pipeline drugs market is Rabies virus Glycoprotein.
Rabies Pipeline Drugs Market Segmentation by Mechanism of Action
The mechanism of action of Rabies pipeline drugs market is Rabies virus Glycoprotein Inhibitor.
Rabies Pipeline Drugs Market Segmentation by Routes of Administration
The routes of administration in the Rabies pipeline drugs market are intramuscular, intradermal, parenteral, injection, intravenous, and subcutaneous.
Rabies Pipeline Drugs Market Analysis, by Routes of Administration
To know more about the RoA in the Rabies pipeline drugs market, download a free report sample
Rabies Pipeline Drugs Market Segmentation by Molecule Types
The molecule types in the Rabies pipeline drugs market are Vaccine, Monoclonal Antibody, Inactivated Vaccine, Recombinant Vector Vaccine, mRNA Vaccine, Subunit Vaccine, Antibody, Live Attenuated Vaccine, Small Molecule, and Oligonucleotide.
Rabies Pipeline Drugs Market Analysis, by Molecule Types
To know more about the molecule types in the Rabies pipeline drugs market, download a free report sample
Competitive Landscape
Some of the leading companies in the Rabies pipeline drugs market are AIM Vaccine Co Ltd, Molecular Targeting Technologies Inc, Yisheng Biopharma Co Ltd, Changchun Bcht Biotechnology Co Ltd, Chongqing Zhifei Biological Products Co Ltd, CPL Biologicals Pvt Ltd, Curevac NV, Sanofi, Vir Biotechnology Inc, and Zydus Lifesciences Ltd among others.
Rabies Pipeline Drugs Market Analysis, by Leading Companies
To know more about the leading companies in the Rabies pipeline drugs market, download a free report sample
Rabies Pipeline Drugs Market Report Overview
| Key Target | Rabies virus Glycoprotein |
| Key Mechanism of Action | Rabies virus Glycoprotein Inhibitor |
| Key Routes of Administration | Intramuscular, Intradermal, Parenteral, Injection, Intravenous, and Subcutaneous |
| Key Molecule Types | Vaccine, Monoclonal Antibody, Inactivated Vaccine, Recombinant Vector Vaccine, mRNA Vaccine, Subunit Vaccine, Antibody, Live Attenuated Vaccine, Small Molecule, and Oligonucleotide |
| Key Companies | AIM Vaccine Co Ltd, Molecular Targeting Technologies Inc, Yisheng Biopharma Co Ltd, Changchun Bcht Biotechnology Co Ltd, Chongqing Zhifei Biological Products Co Ltd, CPL Biologicals Pvt Ltd, Curevac NV, Sanofi, Vir Biotechnology Inc, and Zydus Lifesciences Ltd |
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Rabies (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Rabies (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Rabies (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Rabies (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Rabies (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Rabies (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Rabies (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Beijing Minhai Biotechnology Co Ltd
Changchun Bcht Biotechnology Co Ltd
Chengdu Institute of Biological Products Co Ltd
Chengdu Rongsheng Pharmaceutical Co Ltd
China Medical System Holdings Ltd
Chongqing Zhifei Biological Products Co Ltd
Clover Biopharmaceuticals Ltd
CPL Biologicals Pvt Ltd
Curevac NV
Genrix (Shanghai) Biopharmaceutical Co Ltd
Indian Immunologicals Ltd
Jiangsu Kangrun Biological Technology Co Ltd
Liaoning Cheng Da Biotechnology Co Ltd
Mid-Atlantic BioTherapeutics, Inc.
Molecular Targeting Technologies Inc
Oita University Institute of Advanced Medicine Inc
Prosetta Biosciences Inc
Real Benefitspot Pharmaceutical Co Ltd
Sanofi
Shandong Yidu Biotechnology Co Ltd
Shanghai Bovax Biotechnology Co Ltd
Shanghai Qingsai Biotechnology Co Ltd
Shanghai Rongsheng Biotech Co Ltd
Shenzhen Weiguang Biological Products Co Ltd
Synermore Biologics Co Ltd
Trellis Bioscience Inc
Vir Biotechnology Inc
Yisheng Biopharma Co Ltd
Zydus Lifesciences Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the targets of the Rabies pipeline drugs market?
The target of the Rabies pipeline drugs market is Rabies virus Glycoprotein.
-
What are the mechanisms of action of the Rabies pipeline drugs market?
The key mechanism of action of the Rabies pipeline drugs market is Rabies virus Glycoprotein Inhibitor.
-
What are the top routes of administration in the Rabies pipeline drugs market?
The routes of administration in the Rabies pipeline drugs market are intramuscular, intradermal, parenteral, injection, intravenous, and subcutaneous.
-
What are the molecule types in the Rabies pipeline drugs market?
The molecule types in the Rabies pipeline drugs market are Vaccine, Monoclonal Antibody, Inactivated Vaccine, Recombinant Vector Vaccine, mRNA Vaccine, Subunit Vaccine, Antibody, Live Attenuated Vaccine, Small Molecule, and Oligonucleotide.
-
Which are the leading companies in the Rabies pipeline drugs market?
Some of the leading companies in the Rabies pipeline drugs market are AIM Vaccine Co Ltd, Molecular Targeting Technologies Inc, Yisheng Biopharma Co Ltd, Changchun Bcht Biotechnology Co Ltd, Chongqing Zhifei Biological Products Co Ltd, CPL Biologicals Pvt Ltd, Curevac NV, Sanofi, Vir Biotechnology Inc, and Zydus Lifesciences Ltd among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Infectious Disease reports


